Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00217984 · ClinicalTrials.gov registry record · NA

Intensive Intervention for Smokers - 6

A NA study of Tobacco Use Disorder and Alcohol Dependence, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
162
Enrollment target
1
Study location

NCT00217984 is a NA study of Tobacco Use Disorder and Alcohol Dependence that has completed, run by University of California, San Francisco. The registered enrollment target is 162 participants, below the 237-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (32% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00217984, a NA study of Tobacco Use Disorder and Alcohol Dependence, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
162 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to determine the efficacy and cost-effectiveness of an intensive smoking cessation intervention that utilizes extended cognitive-behavioral therapy and combination nicotine replacement (CNR) in a randomized controlled trial. The intensive intervention was compared to usual care involving referral to a free-standing smoking cessation program that provides brief counseling and CNR. We recruited 162 smokers, ages 18 to 75, who are enrolled in the Drug and Alcohol Treatment (DAT) programs at the San Francisco VA Medical Center (SFVAMC) and Santa Rosa VA Community-based Outpatient Clinic (CBOC). To be eligible, participants had to be abstinent from alcohol for at least one week, but not more than 30 days. We compared outcomes for the two study arms by assessing biochemically-validated point-prevalence smoking status at 3, 6, 9, and 12 months post-baseline and continuous abstinence over the 12-month follow-up. Expired-air carbon monoxide (CO) was used to biochemically verify 7-day point prevalence abstinence. We also conducted an economic analysis to determine the cost-effectiveness of the intensive intervention compared with usual care. We also examined cross-relapse patterns during the follow-up period, assessing changes in mood states and use of tobacco, alcohol, and other drugs at 3, 6, 9, and 12 months.

Interventions

  • OTHER Usual Care
  • BEHAVIORAL Extended cognitive behavior therapy

Study Locations (1)

California

  • VA Medical Center - San Francisco

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2006-07
Est. Completion 2010-06
Phase NA

What the Registry Record Tells You About NCT00217984

The ClinicalTrials.gov registry entry for NCT00217984 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 237-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (32% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT00217984 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00217984 about?

NCT00217984 is a clinical study titled "Intensive Intervention for Smokers - 6". The purpose of this study was to determine the efficacy and cost-effectiveness of an intensive smoking cessation intervention that utilizes extended cognitive-behavioral therapy and combination nicotine replacement (CNR) in a randomized controlled trial. The intensive intervention was compared to us...

What is the current status of trial NCT00217984?

This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2006-07. Estimated completion is 2010-06.

What conditions does trial NCT00217984 study?

This clinical trial studies the following conditions: Tobacco Use Disorder, Alcohol Dependence.

What interventions are being tested in trial NCT00217984?

The interventions under investigation include: Usual Care (OTHER), Extended cognitive behavior therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00217984?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00217984 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.